FGF2 and bladder transitional cell carcinoma: However, treatment with the nonsteroidal anti-inflammatory drug piroxicam, which is considered a standard therapy for dogs with BlCa, led to a decrease in urinary basic FGF (bFGF) levels (77% of treated dogs), and this decrease positively correlated with the reduction in tumor size [84].